The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales

A. C. Crampin, Theresa Lamagni*, V. D. Hope, J. A. Newham, K. M. Lewis, John Parry, Owen Gill

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    28 Citations (Scopus)

    Abstract

    Data on injecting anabolic steroid users, within the national Unlinked Anonymous HIV Prevalence Monitoring Survey of injecting drug users (IDUs) were analysed to determine their risk of acquiring blood borne viruses. One hundred and forty-nine participants who had injected anabolic steroids in the previous month were identified from 1991-6, contributing 1.4% of all participation episodes in the survey. Rates of needle and syringe sharing by steroid users were low. Three of the 149 (2.0%) had anti-HBc and none had anti-HIV in their salivary specimens. The prevalence of anti-HBc in steroid injectors was significantly lower than in heroin injectors, 275/1509 (18%) (P < 0.001), or in amphetamine injectors, 28/239 (12%) (P < 0.001). The risk of blood borne virus transmission amongst these steroid injectors is low, probably due to hygienic use of injecting equipment and low levels of sharing. It is important to distinguish steroid injectors from other IDUs because they are a distinct group in terms of lifestyle and injecting practice.

    Original languageEnglish
    Pages (from-to)381-386
    Number of pages6
    JournalEpidemiology and Infection
    Volume121
    Issue number2
    DOIs
    Publication statusPublished - Oct 1998

    Fingerprint

    Dive into the research topics of 'The risk of infection with HIV and hepatitis B in individuals who inject steroids in England and Wales'. Together they form a unique fingerprint.

    Cite this